{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:28:16Z","timestamp":1783052896510,"version":"3.54.6"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.euroneuro.2020.03.019","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T01:35:23Z","timestamp":1590024923000},"page":"18-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients"],"prefix":"10.1016","volume":"36","author":[{"given":"Nicole","family":"Moschny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Benedictine","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Qayyum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ballmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Liepach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Neyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.03.019_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2018.03.004","article-title":"The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder","volume":"319","author":"Becking","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0002","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0278-5846(02)00255-5","article-title":"Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance","volume":"26","author":"Benedetti","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0003","unstructured":"BioLegend, 2017. Cell Surface Flow Cytometry Staining Protocol. https:\/\/www.biolegend.com\/protocols\/cell-surface-flow-cytometry-staining-protcol\/4283; last accessed: 19.08.2019, 09.26 p.m."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","article-title":"Immune suppression and immune activation in depression","volume":"25","author":"Blume","year":"2011","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0005","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1038\/tp.2013.118","article-title":"Inflammatory activation is associated with a reduced glucocorticoid receptor alpha\/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder","volume":"4","author":"Carvalho","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0006","first-page":"113","article-title":"Increased expression of monocyte CD11b (Mac-1) in overweight recent-onset type 1 diabetic children","author":"Cifarelli","year":"2007","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0007","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0008","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0009","first-page":"388","article-title":"Circulating natural killer cell phenotypes in men and women with major depression: relation to cytotoxic activity and severity of depression","volume":"49","author":"Evans","year":"1992","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1749-6632.1992.tb49146.x","article-title":"Immune changes induced by electroconvulsive therapy (ECT)","volume":"650","author":"Fischler","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jad.2010.11.035","article-title":"Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder","volume":"131","author":"Fluitman","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0012","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1017\/S0033291703001272","article-title":"Clinical response augments NK cell activity independent of treatment modality: a randomized double-blind placebo controlled antidepressant trial","volume":"34","author":"Frank","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.75.1.57","article-title":"The STAR*D study: treating depression in the real world","volume":"75","author":"Gaynes","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0014","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881114552742","article-title":"Acute phase plasma proteins are altered by electroconvulsive stimulation","volume":"28","author":"Glaviano","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2014.08.004","article-title":"Clinical characteristics of inflammation-associated depression: monocyte gene expression is age-related in major depressive disorder","volume":"44","author":"Grosse","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0016","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00213-015-3943-9","article-title":"Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy","volume":"233","author":"Grosse","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/YCT.0000000000000127","article-title":"The immune system and electroconvulsive therapy for depression","volume":"30","author":"Guloksuz","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0018","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0019","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3389\/fimmu.2018.02693","article-title":"Pro-inflammatory monocyte phenotype and cell-specific steroid signaling alterations in unmedicated patients with major depressive disorder","volume":"9","author":"Hasselmann","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0021","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00124509-200312000-00002","article-title":"Raised plasma levels of tumor necrosis factor \u03b1 in patients with depression: normalization during electroconvulsive therapy","volume":"19","author":"Hestad","year":"2003","journal-title":"J. ECT"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with c-reactive protein, IL-1, and IL-6: A meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0023","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.humimm.2012.02.023","article-title":"Association between the human immune response and body mass index","volume":"73","author":"Ilavsk\u00e1","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15622975.2017.1355473","article-title":"Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression","volume":"19","author":"Kranaster","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0024","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0032-1331748","article-title":"Bispectral index monitoring and seizure quality optimization in electroconvulsive therapy","volume":"46","author":"Kranaster","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0026","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00406-018-0910-6","article-title":"A novel seizure quality index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development","volume":"268","author":"Kranaster","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000491401","article-title":"Biomarkers for antidepressant efficacy of electroconvulsive therapy: an exploratory cerebrospinal fluid study","volume":"77","author":"Kranaster","year":"2019","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(01)00399-8","article-title":"Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression","volume":"71","author":"Kronfol","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0029","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1176\/jnp.7.3.295","article-title":"The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT","volume":"7","author":"Krystal","year":"1995","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0029-1212108","article-title":"Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro","volume":"107","author":"Kunt","year":"1999","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0031","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0032","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YCT.0b013e3181571abb","article-title":"Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder","volume":"24","author":"Lehtim\u00e4ki","year":"2008","journal-title":"J. ECT"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0033","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJMct075234","article-title":"Electroconvulsive therapy for depression","volume":"357","author":"Lisanby","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","article-title":"Evidence for an immune response in major depression: a review and hypothesis","volume":"19","author":"Maes","year":"1995","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0035","first-page":"27","article-title":"Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men","volume":"72","author":"Maini","year":"1996","journal-title":"Genitourin. Med."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2249.2010.04272.x","article-title":"Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-cell workshop committee of the immunology of diabetes society","volume":"163","author":"Mallone","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bio.1170100107","article-title":"The influence of age and sex on phagocyte chemiluminescence","volume":"10","author":"McCafferty","year":"1995","journal-title":"J. Biolumin. Chemilumin."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0038","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2009.09.009","article-title":"Depression and immunity: a role for T cells?","volume":"24","author":"Miller","year":"2010","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0040","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0041","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-3223(93)90089-V","article-title":"EEG manifestations during ECT: effects of electrode placement and stimulus intensity","volume":"34","author":"Nobler","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0042","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-244X-12-115","article-title":"Predictors of the short-term responder rate of electroconvulsive therapy in depressive disorders\u2013a population based study","volume":"12","author":"Nordenskj\u00f6ld","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0043","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00019442-200111000-00006","article-title":"The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E","volume":"9","author":"O'Connor","year":"2001","journal-title":"Rep. Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0044","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fimmu.2018.00291","article-title":"T cell phenotype and T cell receptor repertoire in patients with major depressive disorder","volume":"9","author":"Patas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00124509-200112000-00003","article-title":"ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE","volume":"17","author":"Petrides","year":"2001","journal-title":"J. ECT"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0046","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YCT.0b013e31819c76ff","article-title":"Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from core","volume":"25","author":"Petrides","year":"2009","journal-title":"J. ECT"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0047","unstructured":"Pohla, H., 2007. Helmholtz Zentrum Munich CCG Immune Monitoring Protocol: PBMC Isolation, Cryopreservation and Thawing. Version 1.0. www.helmholtz-muenchen.de\/fileadmin\/Immunmonitoring\/pdf\/PBMC_Isolation_Cryo_Thaw.pdf last accessed: 03.10.2019, 2.39 p.m."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0048","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0049","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00213-015-3876-3","article-title":"Increased percentages of regulatory T cells are associated with inflammatory and neuroendocrine responses to acute psychological stress and poorer health status in older men and women","volume":"233","author":"Ronaldson","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2016.06.035","article-title":"Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy","volume":"205","author":"Rush","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0051","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.190.Supp.43.25","article-title":"Abnormalities in regulatory T cells and natural killer cells in major depressive disorder (P3127)","volume":"190","author":"Savitz","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0052","first-page":"81","article-title":"Major depressive disorder and immunity: role of age, sex, severity, and hospitalization","volume":"46","author":"Schleifer","year":"1989","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0053","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2018.01.005","article-title":"A positive feedback loop between IL-1\u03b2, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages","volume":"103\u2013105","author":"Sieve","year":"2018","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000119332","article-title":"Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression","volume":"35","author":"Sluzewska","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0056","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2017.06.011","article-title":"Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: association with sleep disturbance","volume":"66","author":"Suzuki","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0057","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/prca.201100040","article-title":"Proteomic changes induced by anaesthesia and muscle relaxant treatment prior to electroconvulsive therapy","volume":"5","author":"Stelzhammer","year":"2011","journal-title":"Proteomics. Clin. Appl."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0058","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/j.1440-1614.2006.01773.x","article-title":"Seizure threshold determination for electroconvulsive therapy: Stimulus dose titration versus age-based estimations","volume":"40","author":"Tiller","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0059","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders\u00a0: a systematic review and meta-analysis","volume":"361","author":"Carney","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0060","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1038\/tp.2015.100","article-title":"Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?","volume":"5","author":"van Buel","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0061","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0062","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/taap.1996.0068","article-title":"Tricyclic antidepressants inhibit human natural killer cells","volume":"137","author":"Xiao","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0063","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","article-title":"Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review","volume":"11","author":"Yrondi","year":"2018","journal-title":"Brain Stimul. Basic Transl. Clin. Res. Neuromodul."},{"key":"10.1016\/j.euroneuro.2020.03.019_bib0064","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/brbi.2000.0597","article-title":"The relationship of depression and stressors to immunological assays: a meta-analytic review","volume":"15","author":"Zorrilla","year":"2001","journal-title":"Brain. Behav. Immun."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:55:47Z","timestamp":1760378147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":64,"alternative-id":["S0924977X20300948"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.03.019","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}